Bone Quality in Relation to HIV and Antiretroviral Drugs

Arnold Z. Olali, Kelsey A. Carpenter, Maria Myers, Anjali Sharma, Michael T. Yin, Lena Al-Harthi, Ryan D. Ross

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Purpose of Review: People living with HIV (PLWH) are at an increased risk for osteoporosis, a disease defined by the loss of bone mineral density (BMD) and deterioration of bone quality, both of which independently contribute to an increased risk of skeletal fractures. While there is an emerging body of literature focusing on the factors that contribute to BMD loss in PLWH, the contribution of these factors to bone quality changes are less understood. The current review summarizes and critically reviews the data describing the effects of HIV, HIV disease-related factors, and antiretroviral drugs (ARVs) on bone quality. Recent Findings: The increased availability of high-resolution peripheral quantitative computed tomography has confirmed that both HIV infection and ARVs negatively affect bone architecture. There is considerably less data on their effects on bone remodeling or the composition of bone matrix. Whether changes in bone quality independently predict fracture risk, as seen in HIV-uninfected populations, is largely unknown. Summary: The available data suggests that bone quality deterioration occurs in PLWH. Future studies are needed to define which factors, viral or ARVs, contribute to loss of bone quality and which bone quality factors are most associated with increased fracture risk.

Original languageEnglish (US)
Pages (from-to)312-327
Number of pages16
JournalCurrent HIV/AIDS reports
Issue number5
StatePublished - Oct 2022


  • Bone mineral density
  • Bone quality
  • Matrix composition
  • Microarchitecture
  • Remodeling

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases


Dive into the research topics of 'Bone Quality in Relation to HIV and Antiretroviral Drugs'. Together they form a unique fingerprint.

Cite this